Joon Won Jeong

Title: The Innovative Contributions of Joon Won Jeong

Introduction

Joon Won Jeong is a notable inventor based in Belmont, California. He has made significant contributions to the field of pharmaceuticals, holding a total of four patents. His work focuses on developing innovative compounds and methods that have the potential to treat serious medical conditions.

Latest Patents

Among his latest patents is the invention of N-cyano-7-azanorbornane derivatives and their uses. This patent provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, along with pharmaceutical compositions that comprise this compound. It also outlines a method for manufacturing these compounds and their therapeutic uses. Another significant patent is related to KRAS G12C inhibitors, which includes compositions and methods for using these inhibitors. These inhibitors are particularly useful for treating various disorders, including pancreatic, colorectal, and lung cancers.

Career Highlights

Joon Won Jeong has worked with prominent companies in the pharmaceutical industry, including Amgen Inc. and Exelixis, Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the field of cancer treatment.

Collaborations

Throughout his career, Joon has collaborated with esteemed colleagues such as Daniel A. Erlanson and Jeffrey Iwig. These collaborations have further enhanced his research and innovation efforts.

Conclusion

Joon Won Jeong's contributions to the field of pharmaceuticals through his patents and collaborations highlight his commitment to advancing medical science. His innovative work continues to pave the way for new treatments and therapies.